Targeted therapy with galantamine in a pediatric patient with 15q13.3 deletion syndrome
Por:
Casas-Alba D, Nolasco-Tovar GA, Díez M, Mezzatesta M, Balañá G and Fons-Estupina C
Publicada:
1 dic 2021
Ahead of Print:
1 jul 2021
Resumen:
Filiaciones:
Casas-Alba D:
Institut de Recerca Sant Joan de Déu, Barcelona, Spain
Pediatric Neurology Department, Hospital Sant Joan de Déu, Barcelona, Spain
Nolasco-Tovar GA:
Institut de Recerca Sant Joan de Déu, Barcelona, Spain
Pediatric Neurology Department, Hospital Sant Joan de Déu, Barcelona, Spain
Díez M:
Child and Adolescent Mental Health Area, Hospital Sant Joan de Déu, Barcelona, Spain
Institut de Recerca Sant Joan de Déu, Barcelona, Spain
Mezzatesta M:
Institut de Recerca Sant Joan de Déu, Barcelona, Spain
Child and Adolescent Mental Health Area, Hospital Sant Joan de Déu, Barcelona, Spain
Balañá G:
Institut de Recerca Sant Joan de Déu, Barcelona, Spain
Child and Adolescent Mental Health Area, Hospital Sant Joan de Déu, Barcelona, Spain
Fons-Estupina C:
Institut de Recerca Sant Joan de Déu, Barcelona, Spain
Pediatric Neurology Department, Hospital Sant Joan de Déu, Barcelona, Spain
Center for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain
|